AstraZeneca-Daiichi breast-cancer drug Enhertu approved for routine use in England
NICE approved Enhertu for routine use in England after changing its recommendation following the U.S.-U.K. pharmaceutical-pricing deal.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.